I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Kerem, E
436
results:
Online X
Search for persons
X
Format
Online (436)
Mediatypes
E-Books (2)
Articles (Online) (275)
Bookchapter (Online) (5)
OpenAccess-fulltext (154)
Languages
english (400)
german (4)
more...
less...
Sorted by: Relevance
Sorted by: Year
?
1
WS06.05 Long-term outcomes in people with CF lacking early ..:
Hadhud, M.
;
Reiter, J.
;
Meir, E. Ben
...
Journal of Cystic Fibrosis. 23 (2024) - p. S12 , 2024
Link:
https://doi.org/10.1016/..
?
2
WS06.02 First-in-human clinical trial with SPL84, an ASO fo..:
Kerem, E.
;
Caraco, Y.
;
Wanounou, M.
...
Journal of Cystic Fibrosis. 23 (2024) - p. S11 , 2024
Link:
https://doi.org/10.1016/..
?
3
WS02.01 Health inequality in Europe in cystic fibrosis peop..:
Sermet-Gaudelus, I.
;
Orenti, A.L.
;
Hatziagorou, E.
...
Journal of Cystic Fibrosis. 23 (2024) - p. S3 , 2024
Link:
https://doi.org/10.1016/..
?
4
WS06.06 Safety and efficacy of a nebulized phage cocktail i..:
Kerem, E.
;
Rappo, U.
;
Cohen, A.
...
Journal of Cystic Fibrosis. 23 (2024) - p. S12 , 2024
Link:
https://doi.org/10.1016/..
?
5
EPS6.01 Improved outcome in the adult cystic fibrosis popul..:
Orenti, A.
;
Hatziagorou, E.
;
Kerem, E.
..
Journal of Cystic Fibrosis. 23 (2024) - p. S50 , 2024
Link:
https://doi.org/10.1016/..
?
6
ECFS standards of care on CFTR-related disorders: Towards a..:
De Wachter, E
;
De Boeck, K
;
Sermet-Gaudelus, I
...
Journal of Cystic Fibrosis. 23 (2024) 3 - p. 388-397 , 2024
Link:
https://doi.org/10.1016/..
?
7
290 Extending the success of elexacaftor-tezacaftor-ivacaft..:
Kerem, B.
;
Stanleigh, N.
;
Gur, M.
..
Journal of Cystic Fibrosis. 22 (2023) - p. S146 , 2023
Link:
https://doi.org/10.1016/..
?
8
P077 Clinical and functional efficacy of elexacaftor/tezaca..:
Cohen-Cymberknoh, M.
;
Sadras, I.
;
Kerem, E.
...
Journal of Cystic Fibrosis. 22 (2023) - p. S87 , 2023
Link:
https://doi.org/10.1016/..
?
9
WS09.01 Extending the success of Trikafta to rare mutations..:
Stanleigh, N.
;
Gur, M.
;
Kerem, E.
..
Journal of Cystic Fibrosis. 22 (2023) - p. S18 , 2023
Link:
https://doi.org/10.1016/..
?
10
P052 Efficacy of elexacaftor/tezacaftor/ivacaftor in people..:
Yaacoby-Bianu, K.
;
Dagan, A.
;
Cohen-Cymberknoh, M.
...
Journal of Cystic Fibrosis. 22 (2023) - p. S79 , 2023
Link:
https://doi.org/10.1016/..
?
11
P095 A phase 1b/2a randomized, double-blind, placebo-contro..:
Rappo, U.
;
Kahan-Hanum, M.
;
Ussery, X.
...
Journal of Cystic Fibrosis. 22 (2023) - p. S93 , 2023
Link:
https://doi.org/10.1016/..
?
12
116 First-in-human clinical trial with SPL84, an antisense ..:
Caraco, Y.
;
Wanounou, M.
;
Friedman, L.
...
Journal of Cystic Fibrosis. 22 (2023) - p. S61 , 2023
Link:
https://doi.org/10.1016/..
?
13
WS03.01 Differences in disease severity among different res..:
Mei-Zahav, M.
;
Orenti, A.
;
Jung, A.
..
Journal of Cystic Fibrosis. 22 (2023) - p. S5-S6 , 2023
Link:
https://doi.org/10.1016/..
?
14
126 A phase 1b/2a randomized, double-blind, placebo-control..:
Rappo, U.
;
Kahan-Hanum, M.
;
Ussery, X.
...
Journal of Cystic Fibrosis. 22 (2023) - p. S66-S67 , 2023
Link:
https://doi.org/10.1016/..
?
15
P029 Antisense oligonucleotide-based drug development for c..:
Oren, Y.S.
;
Barchad, O. Avizur
;
Galai, E. Ozeri
...
Journal of Cystic Fibrosis. 21 (2022) - p. S68 , 2022
Link:
https://doi.org/10.1016/..
1-15